Standout Papers

Bevacizumab (Avastin®... 2000 2026 2008 2017 745
  1. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook (2020)
    Josep Garcia, Herbert I. Hurwitz et al. Cancer Treatment Reviews
  2. Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (2000)
    Alan B. Sandler, John Nemunaitis et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 10 from Science/Nature 78 standout
Sub-graph 1 of 15

Citing Papers

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
2022 Standout
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
2019 Standout

Works of Alan B. Sandler being referenced

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
2020 Standout
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer
2008

Author Peers

Author Last Decade Papers Cites
Alan B. Sandler 4405 3602 2405 107 7.4k
Rajeshwari Sridhara 4648 2785 2952 137 9.1k
Rogério Lilenbaum 5515 5344 2115 105 8.3k
Philip Bonomi 4803 4349 2075 240 7.8k
Petr Zatloukal 3672 3368 1552 86 5.6k
Glenwood Goss 3530 3433 1621 128 6.2k
Helen X. Chen 4050 2512 3819 83 8.7k
Jyoti D. Patel 3788 3353 1363 224 5.9k
Jean‐Pierre Armand 3673 2015 2592 161 6.8k
Chris H. Takimoto 4707 2460 3504 189 8.7k
Hiroshi Nokihara 3801 3287 1635 236 5.8k

All Works

Loading papers...

Rankless by CCL
2026